English
Polski
Español
українська
COVID-19: CPGs for critically ill patients. Part 7: Other therapeutics
Dr Waleed Alhazzani, lead author of the newest SSC guidelines, talks us through the evidence behind different treatment options (IVIG, antivirals, antimalarials).
2020-04-13
Dr Waleed Alhazzani, lead author of the newest SSC guidelines, talks us through the evidence behind different treatment options (IVIG, antivirals, antimalarials).
Dr Waleed Alhazzani, associate professor in the Division of Critical Care and chair of Surviving Sepsis guidelines, discusses the rationale behind recommendations on steroid therapy in COVID-19 patients with or without ARDS.
Dr Waleed Alhazzani, associate professor in the Division of Critical Care and chair of Surviving Sepsis guidelines, discusses hemodynamic support (vasoactive agents, fluid therapy, neuromuscular blockade).
Dr Waleed Alhazzani, lead author of the newest SSC guidelines, explains recommendations on invasive ventilation, ARDS, and proning.
Dr Waleed Alhazzani, associate professor in the Division of Critical Care and chair of Surviving Sepsis guidelines, reviews ventilatory support recommendations (oxygen levels, noninvasive ventilation, intubation).
Dr Waleed Alhazzani, associate professor in the Division of Critical Care and chair of Surviving Sepsis guidelines, talks in detail about infection control and testing.
Dr Imran Satia, assistant professor in the Division of Respirology at McMaster University and researcher of chronic cough, discusses the practical relevance of the current definitions and management guidelines in chronic cough.
Dr Dominik Mertz, associate professor in the Division of Infectious Diseases at McMaster University and medical director of infection prevention and control at Hamilton Health Sciences, describes the current status of the COVID-19 pandemic and answers some of the commonly repeated questions about testing, immunity, and masks.
Dr Waleed Alhazzani, associate professor in the Division of Critical Care at McMaster University, chair of Surviving Sepsis Campaign (SSC) guidelines, and lead author of the newest SSC guidelines focusing on COVID-19 in the critically ill, talks about developing the first living guidelines to address the novel coronavirus epidemic.
Dr Mark Loeb, professor in the Department of Pathology and Molecular Medicine and Michael G. DeGroote Chair in Infectious Diseases at McMaster University, reviews the essential terminology for discussing the current COVID-19 situation and draws parallels with flu pandemics.
